Published in Br Med J on January 27, 1968
IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique. J Hyg (Lond) (1972) 3.47
Antibody capture radioimmunoassay for anti-rubella IgM. J Hyg (Lond) (1981) 3.38
Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies. J Clin Microbiol (1976) 2.94
Single-sample diagnosis of recent rubella by fractionation of antibody on Sephadex G-200 column. J Clin Pathol (1971) 2.84
Antibody responses in patients with rubella infection determined by passive hemagglutination, hemagglutination inhibition, complement fixation, and solid-phase radioimmunoassay tests. Infect Immun (1978) 2.49
Simplified chromatographic separation of immunoglobulin M from G and its application to toxoplasma indirect immunofluorescence. J Clin Microbiol (1979) 2.22
Solid-phase radioimmunoassay of rubella virus immunoglobulin M antibodies: comparison with sucrose density gradient centrifugation test. J Clin Microbiol (1977) 1.96
A simplified method for the detection of rubella-specific IgM employing sucrose density fractionation and 2-mercaptoethanol. J Hyg (Lond) (1974) 1.90
Enzyme-linked immunosorbent assay that uses labeled antigen for detection of immunoglobulin M and A antibodies in toxoplasmosis: comparison with indirect immunofluorescence and double-sandwich enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.59
Subclass distribution of rubella virus-specific immunoglobulin G. J Clin Microbiol (1985) 1.46
Specific IgM antibody in serum of patients with herpes zoster infections. Br Med J (1972) 1.45
Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen-antibody interaction. Clin Exp Immunol (1969) 1.38
Oligomeric immunoglobulin A antibody response to rubella virus infection. J Clin Microbiol (1978) 1.35
Persistence of immunoglobulin G and immunoglobulin M antibodies after postnatal rubella infection determined by solid-phase radioimmunoassay. J Clin Microbiol (1978) 1.35
Immunofluorescence test for IgM rubella antibodies in whole serum after absorption with anti-gammaFc. Clin Exp Immunol (1975) 1.34
The pattern of immunological responses at various stages of syphilis. Br J Vener Dis (1977) 1.32
Hemadsorption immunosorbent technique for determination of rubella immunoglobulin M antibody. J Clin Microbiol (1981) 1.24
Comparison of enzyme-linked immunosorbent assay (ELISA) and complement fixation test for detection of Mycoplasma pneumoniae antibodies. J Clin Pathol (1983) 1.20
Modified staphylococcal absorption method used for detecting rubella-specific immunoglobin M antibodies during a rubella epidemic. J Clin Microbiol (1977) 1.19
Laboratory diagnosis of rubella: past, present and future. Epidemiol Infect (1991) 1.13
Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodies. J Clin Microbiol (1981) 1.13
Elimination of false-positive cytomegalovirus immunoglobulin M-fluorescent-antibody reactions with immunoglobulin M serum fractions. J Clin Microbiol (1977) 1.08
Lymphoblast proliferation and humoral antibody response after rubella vaccination. Clin Exp Immunol (1973) 1.03
Diagnosis of recent rubella virus infection by demonstration of specific immunoglobulin M antibodies: comparison of solid-phase reverse immunosorbent test with sucrose density gradient centrifugation. J Clin Microbiol (1981) 1.03
Selective reactivity of antibodies to human immunoglobulins G, M, and A with rubella virus proteins. J Clin Microbiol (1985) 0.99
Rapid method to detect rubella immunoglobulin M and immunoglobulin A antibodies. J Clin Microbiol (1975) 0.98
Rapid diagnosis of acute mumps infection by a direct immunoglobulin M antibody capture enzyme immunoassay with labeled antigen. J Clin Microbiol (1985) 0.97
Detection by ELISA of IgM antibodies to Ross River virus in serum from patients with suspected epidemic polyarthritis. Bull World Health Organ (1983) 0.93
Interferon gamma in acute and subacute encephalitis. Br Med J (Clin Res Ed) (1988) 0.92
Laboratory investigations in the assessment of rubella during pregnancy. Br Med J (1968) 0.90
Guillain-Barré syndrome after rubella. Postgrad Med J (1978) 0.89
Rubella serology: applications, limitations and interpretations. Am J Public Health (1972) 0.88
Detection of rubella haemagglutination-inhibition (HAI) and virus-specific IgM antibody using trypsin-treated human group O erythrocytes in the HAI test. J Clin Pathol (1978) 0.87
Clinical evaluation of the sensitivity and specificity of a commercially available enzyme immunoassay for detection of rubella virus-specific immunoglobulin M. J Clin Microbiol (1984) 0.87
Immunological responses in late syphilis. Br J Vener Dis (1980) 0.86
Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection. Clin Diagn Lab Immunol (1998) 0.84
Single-radial-complement-fixation: a new immunodiffusion technique. Assay of the antibody response to the type-specific antigens of influenza virus in post-infection human sera. Bull World Health Organ (1978) 0.83
Hydatid disease in the Western Isles. J Hyg (Lond) (1983) 0.83
Serologically proven acute rubella infection in patients with clinical diagnosis of dengue. Epidemiol Infect (1990) 0.82
Single-serum diagnosis of rubella by combined use of the hemagglutination inhibition and passive hemagglutination tests. J Clin Microbiol (1986) 0.79
Development of a highly specific and sensitive rubella immunoglobulin M antibody capture enzyme immunoassay that uses enzyme-labeled antigen. J Clin Microbiol (1990) 0.78
The immune status of young adult females in Ethiopia to rubella virus infection. Bull World Health Organ (1985) 0.78
Simple technique for separation of concentrated immunoglobulin M fractions by multi-sample gel chromatography and its application to rubella serodiagnosis. J Clin Microbiol (1981) 0.78
Serological diagnosis of rubella. Br Med J (1970) 0.77
[Diagnosis of cytomegalovirus infections in newborn infants and infants: the value of indirect immunofluorescence compared with complement fixation and virus isolation]. Bull World Health Organ (1982) 0.75
Trypsinised human O erythrocytes in the detection of rubella-specific IgM by sera fractionation on sucrose density gradient and absorption with staphylococcal protein A. J Clin Pathol (1981) 0.75
Laboratory diagnosis of rubella. Br Med J (1970) 0.75
Use of the ultracentrifuge vertical rotor in the detection of rubella-specific IgM on a sucrose density gradient. J Clin Pathol (1979) 0.75
Separation of hemagglutination-inhibiting immunoglobulin M antibody to rubella virus in human serum by high-performance liquid chromatography. J Clin Microbiol (1986) 0.75
Therapeutic abortions following rubella infection in pregnancy: the potential impact on the incidence of congenital rubella syndrome. Am J Public Health (1984) 0.75
Reorienting gradient centrifugation in the determination of rubella specific IgM. J Clin Pathol (1980) 0.75
Rubella-virus hemagglutination-inhibition test. N Engl J Med (1967) 14.99
A serological method for demonstrating recent infection by rubella virus. Br Med J (1967) 4.07
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology (1965) 3.50
Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn (1967) 2.89
Congenital rubella. Clinicopathologic, virologic, and immunologic studies. Am J Dis Child (1965) 2.82
Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J (1979) 4.46
Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis (1990) 4.42
Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis (1980) 4.10
Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol (1993) 3.96
Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med (1978) 3.95
Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin. J Exp Med (1975) 3.91
High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation. Biochim Biophys Acta (1978) 3.89
Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol (1994) 3.68
Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet (1984) 3.55
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology (1965) 3.50
Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus. Int J Cancer (1974) 3.24
Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science (1985) 3.17
Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol (1967) 2.95
Distribution of fibroblast surface antigen in the developing chick embryo. J Exp Med (1975) 2.85
Plasmids in Yersinia enterocolitica serotypes O:3 and O:9: correlation with epithelial cell adherence in vitro. Infect Immun (1981) 2.85
Induction of a basement membrane glycoprotein in embryonic kidney: possible role of laminin in morphogenesis. Proc Natl Acad Sci U S A (1980) 2.74
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
External fibronectin of cultured human fibroblasts is predominantly a matrix protein. J Cell Biol (1978) 2.70
Distribution of fibroblast surface antigen: association with fibrillar structures of normal cells and loss upon viral transformation. J Exp Med (1974) 2.62
Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence, prokaryotic expression, and chromosomal localization. J Biol Chem (1989) 2.61
Hantaviruses: genome structure, expression and evolution. J Gen Virol (1996) 2.47
Fibronectin is produced by human macrophages. J Exp Med (1980) 2.44
Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. Pediatr Infect Dis J (1999) 2.38
Novel human serum protein from fibroblast plasma membrane. Nature (1974) 2.35
Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay. J Infect Dis (1980) 2.33
Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc Natl Acad Sci U S A (1978) 2.32
Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr (1995) 2.30
Infectious poliovirus RNA: a sensitive method of assay. Virology (1965) 2.28
Appearance and distribution of collagens and laminin in the early mouse embryo. Dev Biol (1980) 2.27
Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). Arch Gesamte Virusforsch (1965) 2.25
Human caliciviruses in acute gastroenteritis of young children in the community. J Infect Dis (2000) 2.21
Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet (1983) 2.20
Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20
Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19
Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun (1977) 2.18
Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16
Evaluation of a serum IgA-class reticulin antibody test for the detection of childhood celiac disease. J Pediatr (1984) 2.05
ICAM-2 redistributed by ezrin as a target for killer cells. Nature (1996) 2.04
Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem (1998) 2.01
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol (1989) 1.93
Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis (1999) 1.93
Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand (1969) 1.91
Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. Am J Dis Child (1984) 1.91
Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90
In vitro invasiveness of Yersinia enterocolitica isolated from children with diarrhea. J Infect Dis (1978) 1.87
Fibroblast surface antigen produced but not retained by virus-transformed human cells. J Exp Med (1975) 1.81
Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr (1997) 1.80
Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis (1995) 1.79
Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet (1991) 1.79
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol (1987) 1.79
Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia. J Gen Virol (1999) 1.77
Case-control study on Puumala virus infection: smoking is a risk factor. Epidemiol Infect (2009) 1.74
Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr (1985) 1.73
Microvillus-specific Mr 75,000 plasma membrane protein of human choriocarcinoma cells. J Histochem Cytochem (1987) 1.71
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J (1997) 1.71
A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cells. J Exp Med (1976) 1.70
Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet (1997) 1.70
Cultured human monocytes synthesize and secrete alpha2-macroglobulin. J Exp Med (1977) 1.70
Enhancement of invasiveness of Yersinia enterocolitica and Escherichia coli in HEp-2 cells by centrifugation. Infect Immun (1982) 1.67
Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem (1981) 1.66
Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII. Cell (1976) 1.64
Cerebrospinal fluid alterations in herpes simplex virus encephalitis. Rev Infect Dis (1984) 1.64
Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica. Scand J Infect Dis Suppl (1982) 1.62
Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol (1995) 1.61
Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro. Clin Exp Immunol (1971) 1.60
Laminin is produced by early rat astrocytes in primary culture. J Cell Biol (1983) 1.59
Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis (1994) 1.59
Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J Gen Virol (1992) 1.58
Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol (1996) 1.55
Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J Virol (1999) 1.54
Neonatal septicaemia. Arch Dis Child (1985) 1.53
Prognostic factors in childhood acute encephalitis. Pediatr Infect Dis J (1991) 1.53
Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol (1996) 1.52
Human spumaretrovirus in the etiology of sudden hearing loss. Acta Otolaryngol (1993) 1.49
Synthesis and secretion of alpha-2-macroglobulin by cultured adherent lung cells. Comparison with cell strains derived from other tissues. J Clin Invest (1977) 1.48
Distribution of fibronectin in human tissues and relationship to other connective tissue components. Ann N Y Acad Sci (1978) 1.47
Increase in bacteraemic pneumococcal infections in children. Lancet (1995) 1.46
Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine (1995) 1.45
A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill (2011) 1.45
Rapid solid-phase enzyme immunoassay for antibodies to viruses and other microbes: effects of polyethylene glycol. J Immunol Methods (1981) 1.44
Isolation of attenuated rubella-vaccine virus from human products of conception and uterine cervix. N Engl J Med (1972) 1.44
Immunological interspecies cross-reactions of fibroblast surface antigen (fibronectin). Immunochemistry (1976) 1.44
A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatr Scand (1988) 1.43
Cold-insoluble globulin mediates the adhesion of rat liver cells to plastic Petri dishes. Biochem Biophys Res Commun (1977) 1.43
Adherence and toxicity of Yersinia enterocolitica 0:3 and 0:9 containing virulence-associated plasmids for various cultured cells. Acta Pathol Microbiol Immunol Scand B (1983) 1.41
Familial herpes encephalitis. Lancet (1995) 1.40
Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int (1996) 1.40
Genetic analysis of wild-type Dobrava hantavirus in Slovenia: co-existence of two distinct genetic lineages within the same natural focus. J Gen Virol (2000) 1.40
Thy-1 is a neuronal and glial surface antigen which interacts with matrix proteins and plasminogen activator. Exp Brain Res (1990) 1.38
Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child (1995) 1.38
Detection of herpes simplex virus DNA in cerebrospinal fluid samples using the polymerase chain reaction and microplate hybridization. J Virol Methods (1996) 1.38
Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen-antibody interaction. Clin Exp Immunol (1969) 1.38
Dissociation of fibronectin from gelatin-agarose by amino compounds. Biochem J (1978) 1.38
Stimulation of density-inhibited cell cultures by insulin. J Cell Physiol (1973) 1.37
Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol (1996) 1.35